Edgestream Partners, L.P. United Therapeutics Corp Transaction History
Edgestream Partners, L.P.
- $2.29 Billion
- Q4 2024
A detailed history of Edgestream Partners, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Edgestream Partners, L.P. holds 7,117 shares of UTHR stock, worth $2.07 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,117
Previous 4,421
60.98%
Holding current value
$2.07 Million
Previous $1.58 Million
58.52%
% of portfolio
0.11%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding UTHR
# of Institutions
728Shares Held
40.8MCall Options Held
123KPut Options Held
104K-
Black Rock Inc. New York, NY5.47MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.29 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$804 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$641 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$609 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...